Skip To Main Content
Nastaran Barati on Muck Rack

Nastaran Barati

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nastaran

Contact Nastaran, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Potential therapeutic effects of Ivermectin in COVID-19

|
By Nastaran Barati, Shahla Chaichian, Seyedmousa Motavallihaghi, Banafsheh Nikfar
| ncbi.nlm.nih.gov
Skip to main content Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Journal List Exp Biol Med (Maywood) v.247(15); 2022 Aug PMC9442455 As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more about our disclaimer.
Open in Who Shared Issue with article?

Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice

|
By Atefeh Razazan, Jessica Nicastro, Roderick Slavcev, Nastaran Barati
| Nature Verified
Abstract Generating a protective and long-lasting immune response is the primary goal in the expanding field of immunotherapeutic research. In current study we designed an immunogenic bacteriophage- based vaccine to induce a cytotoxic T lymphocyte activity against a mice tumor model over-expressing HER2/neu. Bacteriophage λ displaying a HER2/neu derived peptide GP2 was constructed and used as an anti-cancer vaccine in a BALB/c mouse xenograft tumor model.
Open in Who Shared Issue with article?
See all 2 articles